UNINTENTIONAL MONOTHERAPY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB AND DRUG SURVIVAL RATE OF TOFACITINIB
dc.contributor.author | Inanc, N | |
dc.contributor.author | Abacar, K | |
dc.contributor.author | Ozturk, MA | |
dc.contributor.author | Tufan, A | |
dc.contributor.author | Karadeniz, H | |
dc.contributor.author | Sari, I | |
dc.contributor.author | Can, G | |
dc.contributor.author | Erez, Y | |
dc.contributor.author | Pehlivan, Y | |
dc.contributor.author | Dalkiliç, E | |
dc.contributor.author | Ocak, T | |
dc.contributor.author | Cefle, A | |
dc.contributor.author | Yazici, A | |
dc.contributor.author | Senel, A | |
dc.contributor.author | Akar, S | |
dc.contributor.author | Ediboglu, ED | |
dc.contributor.author | Koca, SS | |
dc.contributor.author | Sagir, RP | |
dc.contributor.author | Yilmaz, S | |
dc.contributor.author | Gulcemal, S | |
dc.contributor.author | Gündüz, ÖS | |
dc.contributor.author | Basibüyük, CS | |
dc.contributor.author | Alkan, S | |
dc.contributor.author | Cesur, TY | |
dc.contributor.author | Onen, F | |
dc.date.accessioned | 2024-07-18T12:07:58Z | |
dc.date.available | 2024-07-18T12:07:58Z | |
dc.identifier.issn | 0003-4967 | |
dc.identifier.other | 1468-2060 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/10733 | |
dc.language.iso | English | |
dc.publisher | BMJ PUBLISHING GROUP | |
dc.title | UNINTENTIONAL MONOTHERAPY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB AND DRUG SURVIVAL RATE OF TOFACITINIB | |
dc.type | Meeting Abstract |